13th balkan biochemical biophysical days & meeting on metabolic disorders’ programme & abstracts
DETERMINATION OF MEASLES VIRUS RECEPTOR ON LYMPHOCYTES
Download 1.91 Mb.
|
- Navigate this page:
- Introduction
- Materials and Methods
- Results and discussion
- References
DETERMINATION OF MEASLES VIRUS RECEPTOR ON LYMPHOCYTESA.K. Pişkin*, P. Akpınar*, B. Anlar *** Hacettepe University, Faculty of Medicine, Department of Biochemistry, Ankara, 06100, Turkey ** Hacettepe University, Faculty of Medicine, Pediatric Neurology Department, Ankara, 06100, Turkey IntroductionMeasles virus ( MV) causes an acute childhood disease which still claims roughly 1 million lives a year. Signalling lymphocyte activating molecule ( SLAM) is an immunoglobulin-like membrane glycoprotein which is expressed on activated T and B lymphocytes is recently shown to be the receptor for MV. This provided an explanation for the immunosupressive effects of MV. Therefore, detection and characterization of SLAM , which is also known as CD 150 or IPO-3 is rather important not only for understanding the molecular basis of MV related pathologies but also for new diagnostic and therapeutic targetting strategies . This study aims at demonstrating the expression of SLAM on lymphocytes by biochemical methods. Materials and MethodsLeukocytes were separated from 10 ml whole blood obtained from healthy volunteers by Ficoll density gradient. Cells were cultured in RPMI 1640 supplemented with 10% FCS . Culture medium contained 16 units/ml LPS and 20 mg/ml Con A. Lymphocytes were collected after 48 hours and cell pellet was lysed in medium containing 1mM Tris HCl, 0.15 mM NaCl, 1mM PMSF and % 0.5 Triton X-100. Lymphocytes that are not activated and HL-60 cells are also cultured to be used as controls. Cell lysates were applied to % 10 SDS- PAGE electrophoresis run at 50 mA for 3 hours. Proteins were transfered to nitrocellulose membrane by Western blot and treated with anti IPO-3 monoclonal antibody. Native gels were also used for separation of lymphocyte proteins and also detected by immunoblotting. Bands were detected by peroxidase staining. Results and discussionIn SDS-PAGE, SLAM band is found to be approximately 70 kD and in activated lymphocytes was larger as compared to that of unstimulated lymphocytes or HL-60 cells. This is in accordance with the stimulous dependent expression of the molecule. SLAM yielded single bands under denaturing and nondenaturing conditions . This indicates that it consists of a single chain and has no subunits. Furthermore, mercaptoethanol treatment did not cause any shift in the size of the molecule. However, SLAM moved very slowly in native gels as compared to that of SDS-PAGE indicating that the glycosilated part consists basicly of neutral glycolipids and/or the protein core is not rich in negatively charged amino acids. It is also found that immunodetection of SLAM is much more efficient when native gels are used. It is concluded that SLAM as an immunodominant molecule may be suppresed by MV enfections and further studies on the characterization of SLAM may reveal insights in molecular immunological mechanisms. References1. Tatsuo, H., Ono, N., Tanaka, K. and Yanagi,Y., SLAM is a cellular receptor for measles virus, Nature, 406: 893-897, 2000. 2. Movaddat, N., Mason, D.W., Atkinson, P.D. et.al, Signalling lymphocytic activation molecule ( CDw150) is homophilic but self-associates with very low affinity. J Biol. Chem., 275(36): 28100-28109, 2000
Ozeren, Muserref Marmara University, Arts and Sciences Faculty, Deparment of Biology, Goztepe Kampusu, Istanbul, Turkey The interaction between human heart myoglobulin and eight specific monoclonal antibodies (mAbs) was investigated with real time biomolecular interaction analysis (RT BIA), using Surface Plasmon Resonance (SPR). The purpose of this study was selection of high affinity mABs for the Nycocard, a rapid quantitative immunoassay format. Analysis of association and dissociation kinetics was monitored in real time, with unlabelled reactants. Antibody isotyping was rapid and simple. Monoclonal antibodies with four different epitope specificities and optimal binding function were selected for a myoglobulin sandwich assay with enhanced sensitivity.
INTERACTION OF ELONGATION FACTOR 2 WITH ACTIN Kıvanç ERGEN1, Aynur KARADENİZLİ2, Fethiye KOLAYLI2, Bent RIIS3
It has been indicated that several components of protein synthetic machinery can bind to actin microfilaments and their interactions with cyotoskeleton can play a role in programmed cell death. One of these components, Elongation Factor 2 (EF-2) is a protein involved in eukaryotic polypeptide chain elongation and promotes transloction in this process. In this study, actin and EF-2 interaction was investigated and an interaction was shown in nearest in vivo conditions using cell homogenates by anti-actin antibody and protein electrophoresis, contributing to the in vitro findings of an interaction between EF-2 and actin. P321 THE EXAMINATION OF THE FUNCTIONAL PROPERTIES OF ADENOVIRUS TYPE 5 E4 ORF3 PROTEIN Emre Koyuncu, Orkide Özge Dirlik, Thomas Dobner Institut für Medizinische Mikrobiologie und Hygiene, LandshuterStr. 22, 93047, Regensburg/Germany emrekoyuncu@lycos.com Adenovirus is one of the mostly used gene therapy vectors to date. However, a major problem is the oncogenic potential of these viruses. E4 ORF3 protein is one of the oncoproteins of Adenovirus Type 5. Besides its oncogenic properties, previous reports have shown that it takes part in viral DNA replication, late viral protein synthesis, and shut-off of host protein synthesis. For this reason, in order to develop a more efficient and safe gene therapy vector, the functions of this protein should be well understood. Most of our knowledge about the functions of ORF3 protein comes from its mutational analysis. It has never been expressed and purified successfully. In this extand, we tried to express ORF3 as a Glutathione-S-Transferase fussion protein in E. coli. At the end, we successfuly expressed and purified not only the wild type ORF3 but also four mutant forms, two of which lacking different regions in N-terminus, and the other two in C-terminus. Moreover, by GST-capture assays, we determined interacting regions of ORF3 with the proteins that have been shown to bind ORF3 in vivo. Our results showed that, C-terminus of ORF3 was important for protein interactions, at least for the proteins we have tested so far. This was also in agreement with the data we had from immunoflourescent analysis. One of the mutant ORF3 having a single amino acid exchange in C-terminus showed completely different localization from the wild type in the cell. The effects of this mutation and other mutations in the same region on viral growth and ORF3’s interacting partners is currently under our investigation. The results of this research will contribute to understanding of the functional properties of ORF3 which is very important for developing adenovirus vectors.
PURIFICATION AND CHARACTERIZATION OF RAT SMALL INTESTINE GLUCOSE-6-PHOSPHATE DEHYDROGENASE Ali DANIŞAN, Deniz CEYHAN, Hamdi ÖĞÜŞ and Nazmi ÖZER
Glucose-6-phosphate dehydrogenase (G-6-PD) catalyzes the first step of the pentose phosphate patway which generates NADPH as reductive power for antioxidant systems and anabolic patways. G-6-PD was purified from the rat small intestine by successively use of homogenization, ultracentrifugation (105000 xg), ion exchange chromatography (DEAE-Fast Flow), dialysis and affinity chromatography (2’,5’-ADP-Sepharose 4B) with a specific activity of of 126 UI/mg protein and a yield of 21 %. PAGE showed three bands on protein staining, only the fast moving band had G-6-PD activity. Km values of enzyme for its substrates , NADP and glucose-6-phosphate, were calculated to to be 22,5 and 61,9 micromolar, respectively. Rat small intestine G-6-PD has a ph optimum of 8.3. The activation energy, activation enthalpy and Q10 for the enzymatic reaction were calculated to be 8516 cal/mole, 7902 cal/mole and 1.59, respectively.
ABDULOVA G. 75 ABOU AUDA M.M. 98 ACAN N.L. 207 ACAR C. 75 ACARTURK E. 140 ACIK L. 113, 114 ADALI O. 178 ADIGUZEL Z. 205 AFRASYAP L. 170, 215 AGACHAN B. 93 AGADJANYAN A.KH. 93 AGAR A. 212, 213 AgGADJANYAN A.A. 93 AGIRBASLI M. 183 AGIRDEMIR H. 143 AGLAMIS S. 174 AK BASOL G. 186 AKALIN N. 82 AKAR S. 100 AKDAG M.Z. 113, 118, 141, 146 AKDENIZ K.G. 195 AKIN A. 86 AKKAN I. 82 AKKAS S.B. 73 AKKAYA O. 210 AKMEMIS C. 170 AKOZ M. 212 AKPINAR P. 216 AKSEN F. 106, 113 AKSOY K. 104, 174 AKSOY Y. 102 AKSU A. 91 AKSU U. 158 AKTAS Z. 115, 116 AKYILMAZ E. 84, 133, 139 AKYOL O. 133, 174, 182 ALABAKOVASKA S. 131 ALAVANTIC D. 153 ALBENIZ I. 126 ALCHUJYAN N. 122 ALEXANDROV I. 158 ALEXANDROVA R. 158 ALEXANDRU D. 156 ALICIGUZEL Y. 213 ALP A. 207 ALTANER C. 158 ALTANEROVA V. 158 ALTANKOV G.P. 166 ALTINISIK M. 195 ALTUNDAL H. 169 ALVER A. 160 AMANVERMEZ R. 199 ANACHKOVA B. 74 ANANIEV E.D. 75, 144 ANANIEVA E.A. 145 ANDREASYAN N.A. 94 ANITA M. 188 ANLAR B. 216 APOSTOLOVA D. 152 ARDICOGLU A. 204, 205 ARI Z. 208 ARICAN A. 179 ARIKAN M.K. 160 ARINC E. 77, 178, 179 ARNAUTOVIC A. 132 ARSLAN B. 213 ARSLAN S. 178 ARSOVA V. 121 ARSOVSKI A. 185 ARTAMONOV M.V. 94, 95 ARTENI A.A. 180 ARTENIE V. 180 ASLAN A. 165, 175 ASLAN B. 164 ASLAN D. 82, 201, 206 ASSA P. 205 ATAMER Y. 79, 177 ATANASOV B. 163 ATANASOVA L. 141 ATANASSOV B. 74 ATAY A. 168, 211 ATMACA G. 127 ATUKEREN P. 158, 214 AVRAM S. 108 AYAR KAYALI H. 171 AYDIN B. 169 AYDIN E. 192 AYDIN S. 209, 213 AYDOGAN S. 191 AYDOGDU N. 127, 147, 148 AYGIT A.C. 114, 115 AYGUN S. 190 AZIBI K. 76 • BABEANU C. 120 BAGIYEVA S. 105, 141, 215 BAIDANOVA V. 144 BAKALOVA N. 131, 135 BAKALOVA R. 105 BAKAN E. 179 BALAN S.A. 155 BANKOVA E. 131 BARAN A. 127, 128 BARICEVIC I. 96 BARIS I. 170, 215 BARISKANER H. 111 BARKUT Y. 136 BARLAK Y. 119 BARSEGYAN K. 122 BARZU O. 74, 159 BASKOL G. 199, 202 BATCIOGLU K. 103, 127 BATUN S. 79, 177 BAY KARABULUT A. 128, 159, 194 BAYIR Y. 165, 175 BAYRAKTAR N. 194 BAYRAMOGLU F. 112 BAYSAL K. 205 BAYSAL S. 127, 128 BEGIC L. 132 BELGE KURUTAS E. 106, 156, 157, 158 BENLI AKSUNGAR F. 96 BERZAL-HERRANZ A. 81 BIBEROGLU G. 89 BICAK E. 127, 128 BIKMAZ B. 126 BIKMAZ K. 126 BIKMAZ P.S. 126 BILGI C. 73, 194 BILGIHAN A. 122, 123 BILGIN M.D. 81 BINGOL B. 210, 214 BODEANU M. 76 BODUR E. 191 BOGDANOVIC G. 177 BOGOJEVIC D. 119 BOJIC D. 146 BOJINOVA V. 144 BOLAMAN Z. 193 BOR-KUCUKATAY M. 212 BOSTANCI M. 82 BOYANOV A. 149 BOYANOVA M. 81 BOYUNEGMEZ T. 179 BOZCARMUTLU A. 179 BOZKURT A. 140 BREWER J.M. 160 BROCK J.H. 155, 160 BROWN K.A. 176 BUBER E. 207 BUGARINOVIC S. 176, 183, 184 BULBUL M. 196 BURCAK G. 197 BURTEA M. 155 BUYUKBESE M.A. 106 BUYUKGEBIZ B. 91, 203 BUYUKYAZI G. 207, 208 • CABA A. 102 CABADAK H. 169 CAKIR A. 165, 175 CAKIR B. 114, 115 CAKIR D.U. 79, 141, 146, 147, 177 CAKIR E. 73, 197 CALISKAN S. 214 CALISKANER P. 168 CAN YILMAZTURK G. 82 CANACANKATAN N. 150 CANDAN N. 161 CANEVARI S. 129 CANIC V. 176 CANORUC N. 79, 177 CANSEVEN A.G. 122, 123 CAPRARU D. 83 CAPRARU M. 83 CAVDAR Z. 196 CELEBI A. 113, 114 CELIK C. 199 CELIK I. 210 CELIK O. 187 CELIK T. 73, 166, 194 CERINIC M. 99 CETIN A. 189 CETINKAYA A. 106 CETINKAYA H. 214 CEYHAN D. 217 CHELU F. 155 CHERNEV P. 86, 172 CHISTOV K.N. 145, 171 CHRISTOU A. 187 CHRISTOV C. 143 CHUBARYAN S.V. 93 CICIK E. 100 CIGERLI S. 164 CIGREMIS Y. 187 CIKIM G. 157 CILDAG O. 195 CIOBANU G 120 COKUGRAS A.N. 191, 192 COLAK M. 119 COLIC N. 146 COLOMBO M. 129 COMAN A.C. 97, 129 CONDAC E. 118 CONSTANTINESCU E. 126 CORIC J. 190 CORUH N. 189, 192, 200 COSKUN G. 137 COSTACHE G. 76 CREANGA D.E. 180, 188, 194 CREANGA I. 180 CUTTONE G. 85 • DAGLAR A. 113, 147, 148 DALDAL F 190, 210 DALKARA T. 78 DALKILIC N. 111, 112 DALMIZRAK O. 78 DANISAN A. 217 DAPCEVIC B. 146 DAS D. 99 DASDAG S. 113, 118 DEDOVIC N. 132 DEGER O. 119, 160 DEJANOV P. 186 DEJANOVA B. 185, 186 DEMAJO M. 85, 105, 106, 121, 168 DEMIR T. 100 DEMIRCEYLAN E. 175 DEMIRCI C. 214 DEMIRCIOGLU A.S. 183, 184 DEMIREL H. 100 DEMIREL I. 111, 112 DEMIREVSKA-KEPOVA K. 110, 111 DEMIRKAZIK A. 150, 165 DEMIROGLU A. 202 DEMIRPENCE E. 193 DENES A.S. 74, 159 DENIZCI A.A. 143, 162 DERIN N. 213 DEVECI R. 186 DIMITRIJEVIC B. 121, 132, 151 DIMITROV I. 145 DIMITROVA R. 81 DIMITROVSKI C. 75 DIMOVSKI A.J. 71 DINCER A. 72, 137, 138 DINCKAYA E. 84, 133, 136, 137, 139 DINIC S. 119 DINU D. 118, 131 DIRLIK O.O. 217 DJUJIC I. 168 DOBNER T. 217 DOBRIKOVA A.G. 136 DOBRIN A. 76, 155 DOGAN A. 206 DOGAN A.L. 193 DOGAN Ayca 193 DOGAN Ayse 150, 165 DOGAN N. 111 DONEVSKA J. 186 DONMA O. 100 DORAN F. 150 DORDEVIC A. 177 DRAGIC M. 121 DRAGOMIR E. 83 DRAMICANIN T. 132 DROSOPOULOS C. 80 DUMAN E. 134, 154, 153 DUNDAR E. 140 DURUKAN H. 78 DUZGUNCINAR O. 193 • ECONOMOU A. 99 EFREMOV G.D. 71, 75 EKERBICER N. 195 EKMEKCI O.B. 100 ELBAKYAN G. 122 ELDEM Y.Y. 130 ELIBOL B. 78 ELMAS O. 213 EMINOGLU M. 196 ENGIZEK T. 172 ENLI Y. 201, 206 ERARSLAN A. 143, 162 ERBAS H. 113, 148, 147 ERCAN A. 78 ERCIYAS F. 211 EREM C. 160 EREN A. 96 EREN N. 164 ERGEN H.A. 93 ERGEN K. 216 ERGENC S. 172 ERGIN H. 201, 206 ERMAN F. 209 ERSOY B. 208 ESKANDARI H. 92 EVRAN S. 137 EYSKENS F. 90, 203, 204 • FADILLIOGLU E. 174 FARBER D.B. 78 FEDINA I. 98, 103, 109 FELLER U. 110 FERRI R. 129 FIGINI M. 129 FILIP C. 102, 103 FILIPCE D. 186 FILIPCE V. 185, 186 FILIPCE V.I. 185 FILIPOVIC D. 101, 139 FISGIN N. 198 FRANGOPOL P. 187 FUSTIK S. 129 • GADJEVA M. 114, 163 GANEA E. 96, 97, 118, 129 GANEV V. 114 GARGILI A. 214 GATEVA P. 94 GEGOVA A. 109 GENC K. 210 GENC M. 103 GENC S. 210 GEORGIEV M. 94 GEORGIEVA K. 98, 103, 109 GEZER S. 156 GHAZARYAN S. 122 GHEORGHITA N. 102, 103 GLISIC S. 153 GLODEANU E. 120 GOCER F. 165 GOKER B. 169 GOKER I. 154 GOKKUSU C. 126 GOKTUG T. 136, 137 GOLDFINE H. 190 GOLTSEV V. 86, 172, 173 GORGULU G. 72, 139 GORGULU S. 72 GRIGOROVA I. 98, 103 GROZDANOV P. 75 GUDUMAC V. 128 GUIDUCCI S. 99 GUJA C. 155 GUL S. 156, 158 GULA N.M. 94, 95 GULDUR T. 194 GULEC M. 133, 174, 182 GULEN S. 113, 114, 115 GULER G. 124 GULTEPE M. 166, 199 GUMUSTAS M.K. 158, 214 GUNAY I. 150, 165, 182 GUNDOGDU U. 142 GUNEBAKAN S. 172 GUNEL-OZCAN A. 178 GUNEN H. 159 GUNER G. 155, 175, 196 GUNGOR O. 116 GURAY T. 72, 139 GURBILEK M. 212 GURKAN H. 107 GUVEN A. 157 GUVENC H.B. 205 GUZEL S.P. 209 GUZELDEREN F.G. 100 GUZVIC M. 132 • HACIEVLIYAGIL S.S. 159 HACIOGLU G. 212 HADJIMITOVA V. 105 HAIRAPETYAN H.L. 94 HALICI M. 165, 167, 175 HALIFEOGLU I. 204, 205, 209 HARDALAC F. 124 HARDING J.J. 96 HASCALIK M. 187 HASCALIK S. 187 HASCELIK G. 197 HATZISTAVROU E. 98 HAZAROSOVA R. 151 HAZNECI E. 103 HEKIM N. 89, 184 HEKIMSOY Z. 168 HELTIANU C. 75, 155 HERLYN D. 129 HLUBINOVA K. 158 HOLZER R. 110 HORVAT A.I. 105, 121 HORVATH A. 114 HOSVER I. 160 HRISTOVA M. 176 • ILHAN B. 111 ILHAN Necip 204, 205 ILHAN Nevin 204, 205 ILIC M. 146 ILIC Z.S. 144 ILKAY E. 205 INANC F. 106, 156, 157, 158 INHAN G.A. 162 IOCHEV M. 85 IONESCU-TIRGOVISTE C. 155 IPCIOGLU O.M. 166, 199 IPEK E. 140 IRAZ M. 133, 174, 182 IRFANOGLU M.E. 113 ISBIR T. 93 ISCAN M. 200 ISGOR B. 200 ISIK B. 113 ISLEKEL H. 214 IVANOV I. 81, 123, 158 IVANOV R. 189 IVANOVIC-MATIC S. 119 • JAKIMOV D. 177 JANAC B. 180 JANEZIC D. 85 JOKANOVIC M. 151, 180 JORDANOVA A.G. 112, 119, 160 JORDANOVA P. 158 JOVANOVIC Z. 153 JOZANOV-STANKOV O. 151, 168 JURANIC Z. 167 • KABALAK T. 153, 154 KACAR S.B. 86 KAHRAMAN H. 205 KALFIN R. 99 KALKAN M.T. 162 KAN B. 169 KANDIL A. 214 KANIT L. 138 KANJER K. 76 KAPLAN A. 79, 177 KAPTANAGASI ORCUN A. 142 KARAALI Z.E. 93 KARAARSLAN I. 88, 198 KARACALI S. 186 KARADAG F. 195 KARADENIZLI A. 216 KARAGYOZOV L. 75 KARAHAN S.C. 160 KARANFILSKA D.P. 71, 75 KARAVELIOGULLARI F.A. 114 KARDESOGLU E. 166 KARSHIKOFF A. 71, 81 KARTAL F. 135 KARUL A.B. 195 KASAPOVIC J. 101, 139 KAYIR H. 73, 194 KAYMAK K. 127, 148, 147 KAYNAR O. 194 KAYRIN L. 150 KAZAN D. 143, 162 KAZANCI N. 170, 171, 213 KAZAZ C. 175 KAZEZOGLU C. 115 KELES S. 167 KELESTIMUR F. 91 KENGIL I. 96 KERIMAK ONER M.N. 162 KESKIN S. 207 KEVORKIAN G. 122 KHMEL T.O. 95 KILIC E. 202 KILIC N. 209 KILINC A. 135 KILINC E. 156 KILINC M. 106, 156, 157, 158 KILINC N. 118 KIRAN H. 157 KISHORE U. 114, 163 KIZIL C. 139 KJURKCHIEV S. 167 KNEZEVIC-USAJ S. 121 KOCABAS V. 212 KOCDOR H. 196 KOCER M. 159 KOCEVA B. 75 KODROV P. 85 KOJIC V. 177 KOJOUHAROVA M. 114, 163 KOLAROSKA D. 101 KOLAYLI F. 216 KOLDAS L. 100 KOLEV D. 131, 135 KOLEVA I. 109 KONUS M. 200 KORICANAC G. 78 KORICANAC L. 85, 106 KORKMAZ F. 211 KORKMAZ M. 205 KORUGAN U. 91 KOSEOGLU M.H. 168 KOSTOVA N.N. 98 KOUZMANOVA M. 176 KOYUNCU E. 217 KOZELOV L. 148 KRSTIC-DEMONACOS M. 109 KRTOLICA K. 121, 132 KUCUK S.H. 197 KUCUKATAY V. 212 KULAKSIZ G. 78 KUNDAK A.A. 148 KUNEVA T. 152 KURAL A. 164 KURALAY F. 210, 214 KURKCUOGLU M. 140 KURTUL N. 179 KUTAY F.Z. 186 KYRIAKIDIS D.A. 87 • LABUDOVIK D. 131 LALCHEV Z.I. 112, 119, 160, 166 LALELI Y. 197 LAMBEV I. 105 LAMBREV P. 86, 173 LARSSON A.K. 102 LASTUN V. 150 LAVCANSKA J. 121 LEAHU R. 188 LEFEVERE M. 203 LUKAREVSKA V. 129 LUPACHYK S.V. 122 LYGEROU Z. 77 • MAFTEI M. 102 MAHURAN D.J. 181 MAJKIC-SINGH N. 146, 153, 162 MALESKA V. 186 MANCEVSKA R. 186 MANDACI S. 190, 210 MANDUTEANU I. 83 MANEA A. 126 MANNERVIK B. 102 MANUKYAN A.V. 93 MARDANYAN S.S. 94 MARINESCU G. 120 MARKICEVIC M. 152 MARKOV D.V. 98 MARKOVA M. 95 MARKOVIC L. 168 MASALCI O. 171 MASLENKOVA L. 109 MEDIC L. 151 MELANI C. 129 MEMISOGULLARI R. 167 MENZILETOGLU S.Y. 104 METE N. 141, 146 MIHAILOVIC M. 119 MIKOSHA O.S. 95 MILAC A. 108 MILEVA K.N. 189 MILLER L.M. 102 MILOVANOVIC S. 124 MINCHEVA J. 143, 144 MIRONOVA R. 81 MITREVSKA S. 101 MIZRAK B. 187 MLADENOV E. 74 MLADNOV D. 94 MODEVA T. 148 MOMIC T. 140 MOUMTZI S. 80 MOUSTAKAS M. 187, 188 MOVSESYAN H. 122 MOVSESYAN N. 122 MRSA V. 82 MUFTUOGLU M. 78 MUHTAROGLU S. 199, 202 MUJAGIC H. 120 MUJAGIC Z. 120 MURGULET C. 194 MUSTATA R.C. 196 MUTLU L.C. 159 • NACHEVA G. 81 NADOLNIK L.I. 122, 125 NAIRA S. 108 NANEV C. 145 NECHIFOR M.T. 118, 131 NECHIFOR Mihai 103 NEDELJKOVIC J. 96 NEDEVA D. 143, 144 NEDIC O. 96 NEICHEVA T. 112, 119 NIATSETSKAYA Z.V. 122, 125 NICHITA N. 149 NICOLAE M. 156 NIKETIC V. 116, 117 NIKOLAVA A. 143, 144 NIKOLIC J.A. 96 NIKOLIC M. 116, 117 NIKOLIC-VUKOSAVLJEVIC D. 76, 152 NIKOLOVSKA E. 186 NIKOLOVSKI M. 94 NIKOYAN A.A. 93 NINIO S. 112, 119 NIWA T. 81 NOVAKOVIC J. 152 • OBA R. 183 OCAL I. 150, 165 OD Z. 95
ODABASOGLU F. 165, 175, 167 ODACI D. 133, 134 ODJAKOVA M. 167, 168, 173 OGUS A. 75, 141, 215 OGUS H. 78, 217 OK E. 202 OKABE H. 155, 175 OKAJIMA K. 155, 175 OKAY S. 140 OKUR E. 157 Directory: 2003 2003 -> Tr-41. 4-03-05-024 Telecommunications 2003 -> Review of some tsunamis in canada 2003 -> The skill of multi-model seasonal forecasts of the wintertime North Atlantic Oscillation 2003 -> 2930 Kerry Forest Parkway 2003 -> Canadian Interuniversity Sport (cis) Athletes of the Week 2003 -> Senior Airman Jason Plite Hometown 2003 -> Technical announcements: My apologies for the comparison pages; they were 2003 -> Pool Play Round 1 9: 20: 00 am 2003 -> 2004 Division II men's Golf Championships Final Round Results deland, fla 2003 -> Go Figure Edited by Kostya Kennedy and Mark Bechtel 645 Passing yards, an ncaa division II record, by University of Indianapolis quarterback Matt Kohn, in a 59-52 victory over Michigan Tech Download 1.91 Mb. Share with your friends:
|